Skip to main content

Venatorx adds potential chronic hepatitis B treatment to its pipeline

The antibiotics developers wants to begin human clinical testing of the new drug candidate during the second quarter of this year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.